Femasys (FEMY) financial statements

Healthcare · Medical Instruments & Supplies · Market cap $113M

Femasys reported revenue of $2M in fiscal 2025, up 17.2% a year over 5 years.

Net income was -$19M and the operating margin -767.0%, against -668.0% in 2020.

Free cash flow was -$19M.

The diluted share count rose 4020% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-0.0-0.0-0.000.0202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Femasys's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Revenue$1M$1M$1M$1M$2M$2M
Cost of revenue$306,533$370,384$441,938$380,069$544,903$872,400
Gross profit$731,385$809,305$764,280$691,901$1M$1M
Research and development$4M$4M$6M$7M$8M$8M
Selling, general and admin$3M$4M$6M$8M$10M$11M
Operating income-$7M-$8M-$12M-$15M-$18M-$18M
Interest expense$12,553$19,226$13,464$165,390$2M$2M
Pre-tax income-$7M-$8M-$11M-$14M-$19M-$19M
Income tax$1,800$4,000$6,300$4,338$9,602$1,297
Net income-$7M-$8M-$11M-$14M-$19M-$19M
EPS (diluted)-$144.00-$22.40-$19.20-$18.60-$17.00-$9.40
Diluted shares0M0M1M1M1M2M
Gross margin70.5%68.6%63.4%64.5%66.6%62.0%
Operating margin-668.0%-706.7%-961.7%-1353.4%-1091.8%-767.0%
Net margin-666.2%-639.0%-944.6%-1329.1%-1155.0%-812.3%

Balance sheet

Fiscal years, from Femasys's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Cash and short-term investments$3M$25M$13M$22M$3M$9M
Receivables$125,790$84,258$77,470$98,906$488,373$616,600
Inventory$131,378$208,270$436,723$667,118$3M$6M
Total current assets$4M$26M$14M$23M$8M$16M
Property, plant and equipment$2M$2M$1M$1M$2M$2M
Total assets$8M$29M$17M$28M$12M$21M
Total current liabilities$3M$2M$2M$3M$9M$4M
Total liabilities$4M$2M$2M$9M$10M$15M
Shareholders' equity-$52M$26M$15M$18M$2M$6M
Net debt-$3M-$25M-$13M-$22M-$3M-$9M

Cash flow

Fiscal years, from Femasys's 10-K filings with the SEC.

Fiscal year202020212022202320242025
Operating cash flow-$5M-$8M-$11M-$11M-$19M-$19M
Capital spending$8,352$306,868$407,475$143,917$761,706$525,007
Free cash flow-$5M-$8M-$11M-$11M-$20M-$19M
Stock-based compensation$318,640$193,366$224,939$675,700$444,147$790,145
Share buybacks (net)——$0-$229,953-$60,753—
Free cash flow margin-476.1%-698.3%-923.5%-1065.7%-1240.3%-837.9%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for FEMY.
Open FEMY in Investingly

Questions

What was Femasys's revenue in 2025?

$2M in fiscal 2025, from its 10-K filing.

How much free cash flow does Femasys generate?

-$19M in fiscal 2025 (operating cash flow minus capital spending).

From Femasys's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.